Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis

Rationale: For treatment of multidrug-resistant tuberculosis, World Health Organization (WHO) guidelines recommend four likely effective drugs plus pyrazinamide (PZA), irrespective of the likely effectiveness of PZA in an individual patient. Whether this regimen should be supplemented in the absence...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Am Thorac Soc
Auteurs principaux: Franke, Molly F., Becerra, Mercedes C., Tierney, Dylan B., Rich, Michael L., Bonilla, Cesar, Bayona, Jaime, McLaughlin, Megan M., Mitnick, Carole D.
Format: Artigo
Langue:Inglês
Publié: American Thoracic Society 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418338/
https://ncbi.nlm.nih.gov/pubmed/25664920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201411-538OC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires